ZA945882B - Bicyclic derivatives of imidazole their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them - Google Patents

Bicyclic derivatives of imidazole their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them

Info

Publication number
ZA945882B
ZA945882B ZA945882A ZA945882A ZA945882B ZA 945882 B ZA945882 B ZA 945882B ZA 945882 A ZA945882 A ZA 945882A ZA 945882 A ZA945882 A ZA 945882A ZA 945882 B ZA945882 B ZA 945882B
Authority
ZA
South Africa
Prior art keywords
alkenyl
medicaments
representing
imidazole
pharmaceutical compositions
Prior art date
Application number
ZA945882A
Other languages
English (en)
Inventor
Alain Corbier
Jean Paul Vevert
Jidong Zhang
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA945882B publication Critical patent/ZA945882B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA945882A 1993-08-05 1994-08-05 Bicyclic derivatives of imidazole their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them ZA945882B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9309654A FR2708612B1 (fr) 1993-08-05 1993-08-05 Nouveaux dérivés bicycliques de l'imidazole, leur procédé de préparation, les nouveaux intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
ZA945882B true ZA945882B (en) 1995-08-07

Family

ID=9449973

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945882A ZA945882B (en) 1993-08-05 1994-08-05 Bicyclic derivatives of imidazole their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US5714508A (xx)
EP (1) EP0638572B1 (xx)
JP (1) JP3766443B2 (xx)
KR (1) KR100349827B1 (xx)
CN (1) CN1054377C (xx)
AT (1) ATE229023T1 (xx)
AU (1) AU690116B2 (xx)
CA (1) CA2129483A1 (xx)
DE (1) DE69431820T2 (xx)
DK (1) DK0638572T3 (xx)
ES (1) ES2183833T3 (xx)
FR (1) FR2708612B1 (xx)
HU (1) HU218379B (xx)
PT (1) PT638572E (xx)
RU (1) RU2141481C1 (xx)
ZA (1) ZA945882B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601847B2 (en) 2004-10-26 2009-10-13 Wyeth Preparation and purification of 4-(indazol-3-yl)phenols

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157026A (en) * 1989-05-30 1992-10-20 Merck & Co., Inc. Oxo-purines as angiotensin II antagonists
JPH04235974A (ja) * 1990-06-08 1992-08-25 Roussel Uclaf 新規なイミダゾール誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
CN1028755C (zh) * 1991-01-04 1995-06-07 赫彻斯特股份公司 咪唑衍生物的制备方法
CA2058198A1 (en) * 1991-01-04 1992-07-05 Adalbert Wagner Azole derivatives, process for their preparation, and their use
TW300219B (xx) * 1991-09-14 1997-03-11 Hoechst Ag
DE4225835A1 (de) * 1992-08-05 1994-02-10 Merck Patent Gmbh Verfahren zur Herstellung von Imidazopyridinen
DE4242459A1 (de) * 1992-12-16 1994-06-23 Merck Patent Gmbh Imidazopyridine
DE4318813A1 (de) * 1993-06-07 1994-12-08 Merck Patent Gmbh Imidazopyridine

Also Published As

Publication number Publication date
FR2708612A1 (fr) 1995-02-10
RU94028266A (ru) 1996-07-10
ATE229023T1 (de) 2002-12-15
CN1112112A (zh) 1995-11-22
DE69431820T2 (de) 2003-05-28
CA2129483A1 (fr) 1995-02-06
US5714508A (en) 1998-02-03
HU9402282D0 (en) 1994-09-28
RU2141481C1 (ru) 1999-11-20
DK0638572T3 (da) 2003-03-24
EP0638572B1 (fr) 2002-12-04
KR950005810A (ko) 1995-03-20
HU218379B (hu) 2000-08-28
KR100349827B1 (ko) 2003-01-08
PT638572E (pt) 2003-04-30
FR2708612B1 (fr) 1996-03-01
JPH07145150A (ja) 1995-06-06
AU690116B2 (en) 1998-04-23
ES2183833T3 (es) 2003-04-01
AU6748994A (en) 1995-02-16
JP3766443B2 (ja) 2006-04-12
DE69431820D1 (de) 2003-01-16
EP0638572A1 (fr) 1995-02-15
HUT70940A (en) 1995-11-28
CN1054377C (zh) 2000-07-12

Similar Documents

Publication Publication Date Title
MY102866A (en) Amide derivatives.
TW224464B (xx)
IL112413A0 (en) Watersoluble azoles, their preparation and pharmaceutical compositions containing them
ZA945882B (en) Bicyclic derivatives of imidazole their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
TW215917B (xx)
ZA997734B (en) Imidazoline compounds, a process for their preparation and pharmaceutical compositions containing them.
HU9400017D0 (en) New preparation process for sulphurated derivatives of imidazole and the new intermediates obtained
ES8403116A1 (es) Procedimiento para la preparacion de pirido (1,4) benzodiazepinas.
GR3018329T3 (en) Novel benzopyran derivatives and processes for the preparation thereof.
HUT77767A (hu) Imidazolszármazékok új alkalmazása, imidazolszármazékok, eljárás előállításukra és a kapott új köztitermékek, gyógyszerkénti alkalmazásuk, és az ezeket tartalmazó gyógyászati készítmények
HUT65376A (en) Process for preparing n,n',n-trisubstituted 5-(diamino-methylene)-1,3-dioxane-4,6-diones and pharmaceutical compositions containing them as active ingredient
IL84266A (en) 1-hydroxyalkyl-3-alkylxanthines and pharmaceutical compositions containing them